Review article on chronic kidney disease

Authors

  • C. Madhavi Latha Department of Pharmacology, Ratnam Institute of Pharmacy, Pidathapolur Village and Post, Muthukur (M), SPSR Nellore District, Pidathapolur, Nellore, Andhra Pradesh 524346
  • CH. Varshitha Ratnam Institute of Pharmacy, Pidathapolur Village and Post, Muthukur (M), SPSR District, Pidathapolur, Nellore, Andhra Pradesh 524346 https://orcid.org/0009-0001-7594-0289
  • P. Hari Babu Ratnam Institute of Pharmacy, Pidathapolur Village and Post, Muthukur (M), SPSR District, Pidathapolur, Nellore, Andhra Pradesh 524346 https://orcid.org/0009-0003-2512-5715
  • SK. Harshiya Ratnam Institute of Pharmacy, Pidathapolur Village and Post, Muthukur (M), SPSR District, Pidathapolur, Nellore, Andhra Pradesh 524346 https://orcid.org/0009-0008-8620-5360
  • L. Charunya Ratnam Institute of Pharmacy, Pidathapolur Village and Post, Muthukur (M), SPSR District, Pidathapolur, Nellore, Andhra Pradesh 524346 https://orcid.org/0009-0001-7594-0289
  • Sreenivasulu M Department of Pharmaceutical Chemistry, Ratnam Institute of Pharmacy, Pidathapolur Village and Post, Muthukur (M), SPSR Nellore District, Pidathapolur, Nellore, Andhra Pradesh 524346

DOI:

https://doi.org/10.26452/ijcpms.v2i4.470

Keywords:

CKD, GFR, ESRD, Dialysis, treatment

Abstract

The hallmarks of chronic kidney/renal disease (CKD) include patient urogenital abnormalities, anatomical abnormalities, or lowered excretory renal function that may indicate the absence of functioning nephrons. The majority of CKD cases have increased mortality and cardiovascular complaint threat. The difficulty in carrying out renal replacement therapy for those with end-stage renal complaints is an issue far and wide around the globe. Low nephron count at birth, nephron loss with aging, and acute or chronic kidney damage brought on by toxic exposures or illnesses are risk factors for the development and progression of CKD (for illustration, obesity, and type 2 diabetes mellitus). Cases with CKD are managed with an emphasis on early discovery or prevention, treatment of the underlying cause to decelerate development, and attention to secondary processes that fuel continued nephron loss. The pillars of remedy include lowering blood pressure, blocking the renin-angiotensin system, and accepting actions adapted to a case's particular condition. Diagnosis and therapy are necessary for CKD consequences such as secondary hyperparathyroidism, metabolic acidosis, and anemia, which impact cardiovascular health and quality of life.

Downloads

Download data is not yet available.

Published

2022-11-04

How to Cite

C. Madhavi Latha, CH. Varshitha, P. Hari Babu, SK. Harshiya, L. Charunya, & Sreenivasulu M. (2022). Review article on chronic kidney disease. International Journal of Clinical Pharmacokinetics and Medical Sciences, 2(4), 146–152. https://doi.org/10.26452/ijcpms.v2i4.470

Issue

Section

Review Article

Most read articles by the same author(s)